What Berlin Pharmaceutical does

Berlin Pharmaceutical Industry Co., Ltd. is a Thai privately held pharmaceutical manufacturer founded in 1932 by Dr. Chai Chainuvati and currently led by CEO Vinda Chainuvati, the founder's daughter-in-law. The company is among the top ten pharmaceutical companies in Thailand by sales, employs more than 900 people, and operates two modern GMP-approved manufacturing facilities on the outskirts of Bangkok, certified to ISO 9001, ISO 17025, and Good Storage and Distribution Practices (GSDP) standards. The business is vertically integrated from API sourcing — with active pharmaceutical ingredients imported from partners in Canada (Apotex), France (Ethypharm), and India (Intas) — through in-house formulation, manufacturing, and direct sales to physicians and pharmacists.

The company's product portfolio spans seven therapeutic categories: cardiovascular drugs (antihypertensives and antiplatelets), antidiabetic medications, antilipemic agents, gastrointestinal drugs, liver and gallbladder medications, central nervous system agents (antiepileptics and AChEI for Alzheimer's), and other products including NSAIDs, anti-infectives, and probiotics. An internal R&D unit develops new formulations, and a long-term partnership with Acino Pharma (Switzerland) extends the portfolio into pain and oncology products marketed in Thailand.

Berlin Pharmaceutical operates a sales-led, field-force go-to-market model in which a dedicated medical representative team delivers products to and supports healthcare providers. The company complements this commercial channel with academic engagement, including the BERLIN DAY conference series, continuing medical education (CME) programs, and disease-awareness outreach. Revenue is generated through one-time sales of generic pharmaceutical products into the Thai healthcare system, with pricing negotiated through healthcare channels. Distribution is single-country/domestic, the company is family-owned with no disclosed external institutional investors, and the associated Berlin Saifon Foundation (established 2002) supports education scholarships for Thai youth.

Name

Berlin Pharmaceutical

Legal name

Berlin Pharmaceutical Industry Co., Ltd.

Website

https://berlinpharmaceutical.com

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Berlin Pharmaceutical Industry Co., Ltd. is a Thai family-owned generics manufacturer, founded in 1932 and ranked among Thailand's top ten pharmaceutical companies. It produces a seven-category portfolio of cardiovascular, metabolic, gastrointestinal, and other medicines at two GMP-certified facilities, selling directly to physicians and pharmacists across Thailand.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Generic pharmaceuticals
• Cardiovascular medications
• Antidiabetic drugs
• Gastrointestinal drugs
• Pharmaceutical manufacturing

Headquarters

HQ city

Pom Prap

HQ country

Thailand

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical product sales: Berlin Pharmaceutical manufactures and sells generic pharmaceutical products primarily for cardiovascular (CV), metabolic, and gastrointestinal (GI) diseases. The company also develops new products through its internal R&D unit and imports active pharmaceutical ingredients (API) from Canada, France, and India. Revenue is generated through the sale of formulated pharmaceutical products to healthcare providers and patients in Thailand.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Berlin Pharmaceutical Industry Co., Ltd. manufactures and sells generic pharmaceutical products in Thailand across seven therapeutic categories: cardiovascular, antidiabetic, antilipemic, gastrointestinal, liver/gallbladder, central nervous system, and other drugs (NSAIDs, anti-infectives, probiotics). The company operates two GMP-approved manufacturing facilities near Bangkok, conducts internal R&D for new formulations, and distributes its products through a dedicated medical representative sales force targeting physicians and pharmacists.

Product overview

Berlin Pharmaceutical Industry Co., Ltd. is a Thai pharmaceutical manufacturer offering a diversified portfolio of generic medications across seven therapeutic categories: cardiovascular drugs (antihypertensives and antiplatelets), antidiabetic medications (oral and injectable), antilipemic agents (statins and fibrates), gastrointestinal drugs (PPIs and motility agents), liver/gallbladder medications, central nervous system agents (antiepileptics and Alzheimer's treatments), and other products including NSAIDs, anti-infectives, and probiotics. The company operates two GMP-certified manufacturing facilities near Bangkok and maintains strategic partnerships with international pharmaceutical companies including Acino Pharma (Switzerland), Apotex (Canada), Ethypharm (France), and Intas (India) for product sourcing and distribution.

Differentiator

Problem solved

Functional benefit

Brands

• มูลนิธิเบอร์ลินสายฝน (Berlin Saifon Foundation): Corporate foundation focused on education scholarships for Thai youth, established in 2002

Products and services

• Cardiovascular Products Cardiovascular medications including antihypertensives (diuretics, ACE inhibitors, ARBs, beta-blockers, calcium channel blockers) and antiplatelet drugs for blood clot prevention, sold to physicians and pharmacists in Thailand.
• Antidiabetic Drugs Oral antidiabetic medications taken with or without meals, and injectable medications including insulin, prescribed for diabetes management.
• Antilipemic Agents Cholesterol-lowering medications including statins (HMG-CoA reductase inhibitors), fibrates, and other dyslipidemia treatments.
• Gastrointestinal Medications Gastrointestinal drugs including proton pump inhibitors (PPIs), gut motility drugs, laxatives, and antispasmodics for digestive conditions.
• Liver Diseases Medications Hepatoprotective drugs for liver disease treatment and medications affecting intestinal secretions for gallbladder disease prevention.
• Central Nervous System Agents Central nervous system medications including antiepileptic drugs and acetylcholinesterase inhibitors (AChEI) for Alzheimer's disease treatment.
• Other Pharmaceutical Products Additional pharmaceutical products including non-steroidal anti-inflammatory drugs (NSAIDs), anti-infectives, and probiotics.
• BG-13 Massage Cream Topical massage cream product for pain relief, distributed as a Berlin Pharmaceutical consumer health product.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Acino PharmacoreStrategic or Co-development PartnerBerlin Pharmaceutical has signed a long-term partnership with Acino Pharma of Switzerland to market a wide range of products from pain treatment to cancer. This partnership enables Berlin to expand its therapeutic reach and bring high-quality products to the Thai market.
• ApotexcoreStrategic or Co-development PartnerBerlin Pharmaceutical has entered into a sourcing arrangement with Apotex, the No. 1 maker of generic pharmaceuticals in Canada. This arrangement supports Berlin's supply chain for generic pharmaceutical products.
• EthypharmcoreTechnology or IntegrationBerlin Pharmaceutical purchases active pharmaceutical ingredients (API) from Ethypharm, a European leader in innovative drug delivery systems. This sourcing arrangement ensures quality APIs for Berlin's pharmaceutical manufacturing.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Intas Pharmaceuticals: India's leading vertically integrated generic formulation, manufacturing and marketing company. Comparable to Berlin as a globalized generic manufacturer (and existing partner) competing in similar chronic-disease generic categories.
• Teva Pharmaceutical Industries: World's largest generic pharmaceutical company offering a broad generic portfolio globally including cardiovascular, CNS and GI categories. Comparable to Berlin as a competing generic supplier in Thailand's open-tender and private-pharmacy channels.
• Viatris Inc. Global healthcare company formed from Mylan-Upjohn combination with extensive generic portfolio across cardiovascular, diabetes and CNS. Comparable to Berlin as a multinational generic supplier active across Southeast Asia in the same molecule categories.
• Sandoz (Novartis): Global leader in generic and biosimilar medicines with broad small-molecule portfolio across cardiovascular, metabolic and GI therapeutic areas. Comparable to Berlin as a global generic competitor active in the Thai market with similar molecule coverage.
• Apotex Inc. Canada's largest generic pharmaceutical manufacturer and Berlin's declared supply-chain partner. Comparable to Berlin as a vertically integrated generic producer with overlapping cardiovascular, metabolic and CNS portfolios.

Emerging players

• Lupin Limited: India-based global generic pharmaceutical company with strong presence in cardiovascular, anti-diabetic and CNS categories. Comparable to Berlin as an emerging global generic competitor targeting similar chronic-disease generic markets including Southeast Asia.

Direct peers

• Greater Pharma Co., Ltd. Thai manufacturer of generic pharmaceuticals sold through physician and pharmacy channels across multiple therapeutic categories. Directly comparable to Berlin as a Thai-based generic pharma company competing in the same domestic market.
• Siam Pharmaceutical Co., Ltd. One of Thailand's established local generic pharmaceutical manufacturers. Comparable to Berlin as a domestic Thai generic producer with branded generic positioning across cardiovascular and metabolic disease categories.
• Olic (Thailand) Co., Ltd. Thai pharmaceutical manufacturer of generic and OTC products with in-house manufacturing in Thailand. Comparable to Berlin as a domestic Thai generic competitor with manufacturing capacity and broad physician-channel distribution.
• Government Pharmaceutical Organization (GPO): Thailand's state-owned pharmaceutical manufacturer producing generic medicines across cardiovascular, metabolic and other therapeutic categories. Directly comparable to Berlin as a domestic Thai generic producer competing for the same hospital and government formulary contracts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/berlinpharma
• LinkedInlinkedin.com/company/berlin-pharmaceutical-industry

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Berlin Pharmaceutical